ABSTRACT
INTRODUCTION
Monochorionic monoamniotic twinning accounts for about 1-2% of monozygotic twin pregnancies worldwide [1] [2] [3] [4] [5] [6] . Monoamniotic twins are at increased risk of perinatal complications compared with monochorionic diamniotic or dichorionic twin pregnancies [3] [4] [5] . Perinatal mortality is reported to be high in monoamniotic twins, primarily owing to cord entanglement 5 . Early-and mid-pregnancy loss before 26 weeks' gestation seems to be correlated mainly with the incidence of twin reversed arterial perfusion (TRAP) sequence, conjoined twins and major congenital anomalies, the rate of these complications being as high as 60% in studies evaluating high-risk referred populations 5, 7 . Regarding pregnancy loss after 26 weeks, the largest review of monoamniotic twins, including 60 studies and 133 non-conjoined monoamniotic twin pregnancies, reported a non-anomalous perinatal mortality rate of about 20%, with a significant rise in mortality after 32 weeks' gestation 4 . These data are often used to justify planned preterm delivery from 32 weeks in otherwise uncomplicated monoamniotic twins 5, 8 ; however, robust data on which a decision about the timing of delivery can be based are missing.
Inpatient management of monoamniotic twin pregnancies from viability until delivery has been reported 5 . No recommendation has been made on whether these women should be managed in hospital or whether they can be managed safely in an outpatient setting, and The American College of Obstetricians and Gynecologists (ACOG) concluded that 'the optimal management of these patients remains uncertain' 8 .
The aim of this study was to compare the perinatal outcomes of inpatient vs outpatient fetal surveillance approaches employed in 22 participating study centers, and to calculate the fetal and neonatal death rate according to gestational age, in non-anomalous monoamniotic twins at ≥ 26 weeks' gestation.
SUBJECTS AND METHODS

Study design and participants
This was a multinational, retrospective, cohort study of pregnant women with a monochorionic monoamniotic twin pregnancy who were referred to 22 university hospitals in Italy, the USA, the UK and Spain (Table 1) between January 2010 and January 2017. Clinical records were collected in a dedicated merged database. Only women with a confirmed diagnosis of monoamnionicity after delivery were included.
All reported variables were collected for all the subjects included in the study. Inclusion criteria were gestational age of at least 26 + 0 weeks with both fetuses alive, and confirmation of monoamnionicity at delivery and/or by pathologic examination of the placenta. Only uncomplicated monoamniotic twin pregnancies were included. Exclusion criteria were pseudomonoamnionicity (iatrogenic creation of a single amniotic space because of an invasive procedure); conjoined twins; major fetal abnormality; intrauterine growth restriction (IUGR) or selective IUGR (i.e. one or both fetuses with ultrasound-estimated fetal weight < 10 th centile); twin-to-twin transfusion syndrome; TRAP sequence; acardiac twins; spontaneous miscarriage before 26 weeks; and higher-order multiple pregnancies. Women who underwent selective reduction were also excluded. Therefore, all women included in the study had a non-anomalous uncomplicated monoamniotic twin pregnancy with both fetuses alive at 26 weeks.
In 10 of the centers, all monoamniotic twins were managed routinely as inpatients, while in the other 12 centers all monoamniotic twins were managed routinely as outpatients (Table 1) . In outpatient care, frequent follow-up was employed, with regular evaluation of fetal wellbeing by ultrasound assessment of fetal growth (fetal biometry of both twins and amniotic fluid volume assessment using deepest vertical pocket) every 3 weeks, ultrasound Doppler (umbilical artery Doppler and middle cerebral artery peak systolic velocity for both twins) every 2 weeks 9 , and non-stress tests (NST) usually once a week with either standard NST or computerized cardiotocography.
Women managed as inpatients were admitted from 24 + 0 to 29 + 0 weeks until delivery. Patient management in this group included NST two or three times a day, ultrasound assessment of fetal growth every 3 weeks and Doppler ultrasound every 2 weeks (Table 1) 9 . Continuous fetal heart rate monitoring was not performed in any of the participating centers.
All women in the inpatient group (study group) were delivered following one admission. For women included in the outpatient group (comparison group), who had one or more admissions, the total length of stay was calculated.
In both groups, planned Cesarean delivery was scheduled usually at 32 + 0 to 34 + 6 weeks, according to local protocols and at the provider's discretion (Table 1) 8,10 . Any indication for earlier delivery was recorded. Antenatal corticosteroids for fetal lung maturation were offered before planned Cesarean delivery. Assessment of cervical length by transvaginal ultrasound for the prevention of preterm birth was not performed routinely in either group, given the lack of treatment for twin pregnancies with a short cervix [11] [12] [13] [14] [15] [16] .
Outcomes
Primary and secondary outcomes were compared between the inpatient and outpatient groups. The primary outcome was intrauterine fetal death (i.e. stillbirth) after 26 weeks' gestation. Secondary outcomes were gestational age at delivery, total antenatal maternal length of stay (LOS) in the hospital, indication for delivery, birth weight, LOS in the neonatal intensive care unit (NICU) (days from admission to the NICU until discharge), neonatal death (i.e. death of a liveborn baby within the first 28 days postpartum) and perinatal death (i.e. either fetal or neonatal death).
We also planned to assess fetal and neonatal death rates according to gestational age at 1-week intervals; this secondary analysis was performed separately for the inpatient and outpatient groups. Ultrasound (US) assessment of fetal growth included fetal biometry of both twins and amniotic fluid volume assessment using deepest vertical pocket method. US Doppler assessment included umbilical artery Doppler and middle cerebral artery peak systolic velocity assessment, in both twins. CCTG, computerized cardiotocography; NST, non-stress test.
Statistical analysis
Statistical analysis was performed using the Statistical Package for Social Sciences (SPSS) v. 19.0 (IBM Inc., Armonk, NY, USA). Data are shown as mean ± SD, median (range) or n (%). Univariate comparisons of dichotomous data were performed using the chi-square test with continuity correction. Comparisons between groups were performed using the t-test to test means with SD by assuming equal within-group variance, and the Mann-Whitney U-test to test group medians with range. Primary and secondary outcomes are presented as odds ratios (ORs) with 95% CIs 17 . In addition to standard logistic regression analysis, in which each fetus was treated as an independent unit, we used a generalized mixed-model approach in which each twin pair was a cluster unit. This model was used because the outcome of a twin is not independent of that of its cotwin. Two-sided P-values were calculated, and P < 0.05 was considered to indicate statistical significance 18 . The study was reported following the STROBE guidelines 19 .
RESULTS
In total, 195 consecutive women with a non-anomalous uncomplicated monoamniotic twin pregnancy (390 fetuses) and both fetuses alive at 26 weeks, were included in the study (Figure 1 ). Of these, 75 (38.5%) women were managed as inpatients and 120 (61.5%) as outpatients. Inpatient and outpatient management policies were highly variable between the included centers. Inpatient monitoring usually started at about 26 weeks' gestation, whereas in the outpatient group monitoring was usually instituted after 30 weeks (Table 1) . Demographic characteristics were similar between the two groups ( Table 2 ). Mean maternal age was about 30 years in both groups. One woman in the inpatient group and one in the outpatient group had a history of stillbirth in a prior pregnancy.
Primary analysis
Based on standard logistic regression analysis, nonanomalous uncomplicated monoamniotic twin pregnancies managed as inpatients from 26 weeks to delivery had a significantly lower rate of intrauterine fetal death ( (Table 3) . However, based on generalized mixed-model analysis considering each twin pair as a cluster unit, non-anomalous uncomplicated monoamniotic twin pregnancies managed as inpatient had a similar rate of intrauterine fetal death as did those managed as outpatient (raw rates: 3.3% vs 10.8%; adjusted OR, 0.21 (95% CI, 0.04-1.17); Table 4 ).
Indications for delivery are shown in Table 5 . 70.7% of the women in the inpatient group and 68.3% of the women in the outpatient group delivered via scheduled Cesarean section on the planned date.
Secondary analysis
The overall fetal, neonatal and perinatal death rates in our cohort were 7.9% (31/390), 2.8% (11/390) and 10.8% (42/390), respectively. Four (5.3%) women in the inpatient group and 15 (12.5%) in the outpatient group experienced intrauterine fetal death. Details of fetal, neonatal and perinatal deaths according to gestational age at delivery are shown in Tables 6, S1 and S2, respectively.
The intrauterine fetal death rate per 1-week gestationalage interval ranged from 0% to 4.3%. The highest weekly intrauterine fetal death rate was observed between 29 + 0 and 29 + 6 weeks, in both the inpatient group (rate, 2.0%) and the outpatient group (rate, 6.0%).
From 32 + 0 to 36 + 6 weeks, no fetal or neonatal death occurred in either group (Tables 6 and S1) (Table S2) . Data are presented as n, mean ± SD or n (%). *Standard logistic regression analysis, in which each fetus was treated as an independent unit. †Outcomes based on liveborn babies only. LOS, length of stay; NICU, neonatal intensive care unit; OR, odds ratio. 
DISCUSSION
Main findings
In addition to the general risks of monochorionicity and twin pregnancy, monoamniotic twins are at greatly increased risk of neonatal death owing to umbilical cord entanglement. In the past, these risks have been associated with a loss rate as high as 70% 5, [13] [14] [15] [16] [17] [18] [19] [20] . In this cohort of 390 uncomplicated monoamniotic fetuses, the overall rate of perinatal death was 10.8%.
Based on standard logistic regression analysis, in which each fetus was treated as an independent unit, the rate of intrauterine fetal death was significantly lower in the women managed as inpatients than in those managed as outpatients. We also observed an improvement in neonatal outcomes, with inpatient management associated with a shorter LOS in the NICU. However, using generalized mixed-model analysis, with each twin pair treated as a cluster unit, the rate of intrauterine fetal death was similar between inpatient-and outpatient-management groups. Therefore, our study shows that when treating each fetal death as an independent event, there appears to be a statistically significant difference between inpatient and outpatient groups. However, because second twins have an increased risk of fetal death after the death of a first twin, this finding did not reach statistical difference when twin pairs were analyzed as a cluster unit.
Inpatient monitoring usually started at about 26 weeks' gestation, whereas monitoring was delayed until 30 weeks in the outpatient group. Our study showed that the difference in fetal mortality between the inpatient and the outpatient groups mainly occurred in the 26-30-week window, and that once monitoring has been instituted (be it in the inpatient or in the outpatient group) survival of monoamniotic twins is excellent, and outcomes of inpatient and outpatient groups are similar. Therefore, this study shows clearly that close monitoring is needed to achieve good outcomes in monoamniotic pregnancies, regardless of the surveillance setting.
An important finding of this study is the markedly improved perinatal survival compared with that reported in older literature. This could be explained by improvements in the diagnosis and treatment of monoamniotic twin pregnancies but also by the fact that most losses in these pregnancies are attributable to fetal abnormalities and spontaneous early miscarriage 5 , which were excluded from our study. Therefore, these data may truly represent the natural history of non-anomalous uncomplicated monoamniotic twins once viability has been reached.
Our secondary analysis also showed that fetal death in non-anomalous uncomplicated monoamniotic twins occurred up to 31 + 6 weeks. Indeed, the major important and novel finding of the MONOMONO study was the lack of 'late-gestational-age' deaths, suggesting that putting back the planned timing of delivery from 32 to 34 + 6 weeks may be a safe approach for pregnant women with an uncomplicated monoamniotic twin pregnancy. However, while no deaths occurred after 34 weeks, only 23 pregnancies continued beyond this gestation, hence the study was underpowered to draw conclusions on the optimal timing of delivery to avoid stillbirth. Data are presented as n (%). *One case of pre-eclampsia. †Four cases of pre-eclampsia; two cases of placental abruption. OR, odds ratio. The most important limitation of our study was the retrospective non-randomized approach. Owing to the retrospective nature of the study, it was not possible to separate the importance of hospitalization vs the increased frequency of testing per se. Because this was not a randomized comparison, the findings were subject to bias. Moreover, since continuous fetal heart rate monitoring was not performed in any of the institutions following inpatient management, it was not possible to assess whether such a monitoring approach could further decrease the rate of fetal death. Inpatient and outpatient management were highly dissimilar between the included centers (Table 1) , and therefore variations in management among the different institutions could have influenced our findings. Data on patient satisfaction, neonatal outcomes and economic implications were not available.
Comparison with the literature and implications
Several small studies evaluating perinatal outcomes in monoamniotic twins have been published (Table  S3) 7,20-26 . In a retrospective study, Heyborne et al. 20 assessed the effectiveness of inpatient monitoring of monoamniotic twins, and observed improved neonatal survival among women who were admitted electively for inpatient monitoring. On the other hand, Van Mieghem et al. 22 concluded that if close fetal surveillance is instituted after 26-28 weeks and delivery takes place at approximately 32-34 weeks, the risk of perinatal complications is low, regardless of the surveillance setting.
Fetal demise is a major concern as a monoamniotic twin pregnancy approaches term, and early delivery would prevent this occurrence. It is indeed common for monoamniotic twins to be delivered preterm with planned Cesarean section at about 32 weeks' gestation 5, 8 . In 2016, the Royal College of Obstetricians and Gynaecologists, ACOG and the Society for Maternal Fetal Medicine recommended that monoamniotic twin pregnancies should be delivered by Cesarean section between 32 and 33 weeks because of the high risk of intrauterine fetal death 8, 27 . These recommendations are based on studies demonstrating that the perinatal mortality rate roughly doubles beyond 34 weeks (7%) compared with that at 33 weeks (4%) 4 . However, the justification for preterm delivery should be balanced against the likelihood of respiratory distress syndrome (5%) at 32 weeks 1, 7 , despite the use of antenatal steroids [28] [29] [30] in otherwise uncomplicated pregnancies 1, 3, 4, 8 . This balance may not be achieved if fetal loss in uncomplicated monoamniotic twins is low 1, 4 . Our study showed no fetal or neonatal death between 31 + 6 weeks and 36 + 6 weeks.
Conclusions
In uncomplicated monoamniotic twins, inpatient surveillance is associated with similar fetal mortality to that of outpatient management. As the raw rates of fetal mortality were 3.3% in the inpatient group and 10.8% in the outpatient group, further research is necessary.
Our data also suggest that, in non-anomalous uncomplicated monoamniotic twins, the fetal and neonatal death rates do not increase after 32 + 0 weeks, therefore planned Cesarean delivery at 33 + 0 to 34 + 6 weeks is a reasonable strategy to discuss with the patient. Data beyond 34 weeks are too limited to make a recommendation. Owing to the retrospective nature of this study, caution should be exercised before changes in practice are employed. A randomized controlled trial would provide the best evidence on the preferred method of monitoring for monoamniotic twins, however, this would be logistically difficult given the rarity of such pregnancies.
